scispace - formally typeset
B

Benjamin M. Petre

Researcher at Harvard University

Publications -  7
Citations -  3762

Benjamin M. Petre is an academic researcher from Harvard University. The author has contributed to research in topics: Ligand (biochemistry) & Golgi apparatus. The author has an hindex of 7, co-authored 7 publications receiving 3577 citations.

Papers
More filters
Journal ArticleDOI

Neurodegenerative disease: amyloid pores from pathogenic mutations.

TL;DR: It is shown that mutant amyloid proteins associated with familial Alzheimer's and Parkinson's diseases form morphologically indistinguishable annular protofibrils that resemble a class of pore-forming bacterial toxins, suggesting that inappropriate membrane permeabilization might be the cause of cell dysfunction and even cell death in amyloids diseases.
Journal ArticleDOI

Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling

TL;DR: It is shown that a highly bent integrin conformation is physiological and has low affinity for biological ligands.
Journal ArticleDOI

α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils

TL;DR: Two mutations in the alpha-synuclein gene (A30P and A53T) have been linked to autosomal dominant early-onset Parkinson's disease and the formation of pore-like oligomeric structures may explain the membrane permeabilization activity of alpha- synuclein protofibrils.
Journal ArticleDOI

Mixtures of Wild-type and a Pathogenic (E22G) Form of Aβ40 in Vitro Accumulate Protofibrils, Including Amyloid Pores☆

TL;DR: Biophysical studies revealed that the Arctic mutation accelerates both Abeta oligomerization and fibrillogenesis in vitro and an increase in the ratio of Abeta(WT)/Abeta(MUT(Arctic)), therefore, may result in the accumulation of potential neurotoxic protofibrils and acceleration of disease progression in familial Alzheimer's disease mutation carriers.
Journal ArticleDOI

Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes.

TL;DR: It is demonstrated that, in vitro, PA28 can associate with 'singly capped’ 26S (i.e. 19S–20S) proteasomes, and during breakdown of proteins, the complexes containing PA28β or PA28α generated a pattern of peptides different from those generated by 26S proteasome, without altering mean product length.